EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Since 2008, when the first EULAR recommendations for the management of systemic lupus erythematosus (SLE) were published and widely adopted,1 a series of specific recommendations on disease monitoring ...

People with lupus have a higher risk of hearing loss due to inflammation that can damage the inner ear and auditory pathways. Hearing loss is a lesser-known complication of lupus, but it can ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Objective To assess the efficacy and safety of the type I interferon receptor antibody, anifrolumab, in patients with active, biopsy-proven, Class III/IV lupus nephritis. Methods This phase II ...

Background: The Mycophenolate Steroids Sparing (MYSS) study showed that, when combined with ciclosporin microemulsion, mycophenolate mofetil is not superior to azathioprine in preventing acute ...